Casey Means' Inactive Medical License Comes Under Scrutiny
President Donald Trump's nominee for U.S. surgeon general has sparked scrutiny online as her Oregon medical license has been inactive since 2019.
While U.S. surgeons general are not required to have an active medical license while serving in the position, Casey Means' nomination has ignited a debate about transparency and professional qualifications for the role.
Nicole Shanahan, Health Secretary Robert F. Kennedy Jr.'s running mate in the 2024 presidential election, wrote on X, formerly Twitter, "I was promised that if I supported RFK Jr. in his Senate confirmation" that Means would not work under the Department of Health and Human Services (HHS).
She added, "I don't know if RFK very clearly lied to me, or what is going on."
Newsweek contacted HHS for comment via email outside regular working hours. Means, who was not immediately reachable via her social media accounts, was also contacted via an email to the department.
While most surgeons general have a medical or public health background, holding an active medical license is not a statutory or regulatory requirement for the position.
However, Means' nomination has raised questions about professional representation in the health and wellness industry. As medical influencers gain vast followings online, there is growing concern over how credentials are communicated—and whether audiences are being misled about an expert's active medical authority.
Means is a physician turned entrepreneur who earned her undergraduate and medical degrees at Stanford University. She trained in otolaryngology—ear, nose and throat surgery—before leaving clinical practice to focus on what she described as "root-cause resolution medicine" and systems-based approaches to health.
Means co-founded Levels in 2019, a company that promotes continuous glucose monitoring for nondiabetic users as a tool for metabolic optimization.
She has written extensively about the relationship between diet, lifestyle and metabolic health, and she often uses social media and public speaking engagements to advocate for personalized wellness strategies.
Means is a vocal supporter of Kennedy and his agenda to "Make America Healthy Again."
In February, she celebrated his confirmation as health secretary, writing on X, "@RobertKennedyJr has a vision for the future that aligns with what I want for my family, future children, and the world."
Calley Means, her brother, was also recently appointed as a White House adviser on the "Make America Healthy Again" campaign.
According to publicly available records from the Oregon Medical Board, Means' license was granted in 2014 and transitioned to an inactive status five years later, in July 2019.
An inactive license means she is no longer authorized to practice medicine or prescribe medication, although there is no indication of disciplinary action or revocation.
Her continued use of the "Dr." honorific and promotion of health interventions has prompted backlash from physicians who argue that it blurs the line between credentialed medical advice and wellness entrepreneurship.
Conservative commentator Laura Loomer wrote on X: "Casey Means, the new Trump nominee for US Surgeon General doesn't even have an active medical license in Oregon when she established her medical practice. How is the top doctor in the US supposed to give medical guidance and advice to the nation when she doesn't even have an active medical license in the state where she allegedly practiced medicine? Does Casey Means even have an active medical license in any state?? This is so embarrassing for the Trump administration."
She wrote in a separate post: "Surgeon General is a very interesting term. The Surgeon General is the nation's top doctor, responsible for providing medical advice and leadership on public health issues. It is worth noting that Casey Means doesn't have a surgical residency, and isn't a surgeon. The term Surgeon General is interesting given the fact that there is no requirement to be a Surgeon to be Surgeon General. Turns out you can be a social media influencer and become Surgeon General."
Dr. Mary Talley Bowden, the founder of Americans for Health Freedom, wrote on X: "Shouldn't the surgeon general have an active medical license?"
Nicole Shanahan, a lawyer and Robert F. Kennedy Jr.'s former running mate, wrote on X: "Yes, it's very strange. Doesn't make any sense. I was promised that if I supported RFK Jr. in his Senate confirmation that neither of these siblings would be working under HHS or in an appointment (and that people much more qualified would be). I don't know if RFK very clearly lied to me, or what is going on. It has been clear in recent conversations that he is reporting to someone regularly who is controlling his decisions (and it isn't President Trump). With regards to the siblings, there is something very artificial and aggressive about them, almost like they were bred and raised Manchurian assets."
Means must be confirmed by the Senate before she can assume the role of surgeon general.
Related Articles
Who is Casey Means? Trump Nominates Wellness Influencer as Surgeon GeneralRFK Jr. Gives Update on Autism Research Involving Medicare, Medicaid MembersWho Is Vinay Prasad? RFK Jr. Taps Pharma Critic to Lead FDA Vaccine ProgramRFK Jr Says Vaccine Contains 'Aborted Fetus Debris'
2025 NEWSWEEK DIGITAL LLC.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Pennsylvania lawmakers advance bill expanding no-cost breast cancer diagnostics
HARRISBURG, Pa. (WHTM) — Pennsylvania was one of the first states to require insurance companies to cover breast cancer screenings for high-risk women. Now, lawmakers want to expand on the law. Senate Bill 88 passed out of the insurance committee unanimously on Tuesday. The bill would clarify that insurance companies must cover screenings and diagnostics with no out-of-pocket costs for not just high-risk women but average-risk women, too. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now That covers just about everyone. Governor Josh Shapiro signed Act 1 into law in 2023 as the first bill of his administration. The law, which unanimously passed the Senate and House, required insurance companies to pay for preventative care such as genetic testing, MRIs, and ultrasounds for women at high risk of breast cancer. Insurance companies covered the screenings, but some still charged women for diagnostics if something was found. Governor Shapiro signs historic breast cancer screening bill 'But we know that screening is just one part of early detection, and far too many patients are still being hit with costs for the diagnostic imaging they need next,' said Senate President Pro Tempore Kim Ward (R-Westmoreland), who co-sponsored the bill. 'It's time to finish what we started and make sure every woman has access to the full range of breast imaging, including diagnostic exams, without cost standing in the way.' The bill now heads to the Senate for consideration, where it is likely to pass. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
34 minutes ago
- Yahoo
Takeaways from AP's report on financial interests of RFK Jr. adviser who runs wellness platform
ASSOCIATED PRESS (AP) — Calley Means has built a following by railing against the U.S. health system, often hammering on alleged financial conflicts within the medical establishment. Means, a top aide to Health Secretary Robert F. Kennedy Jr., was hired as a White House adviser in March. He has used that position to accuse physician groups, federal agencies and government scientists of financial interests that bias their work. Means, however, has his own stake in the sprawling health system. He's the co-founder of an online platform that offers dietary supplements, herbal remedies, exercise equipment, light therapy lamps and other wellness products. The Associated Press found that Means' heated rhetoric against the medical mainstream dovetails with the interests of his company TrueMed, which features vendors who are prominent supporters of Kennedy's 'Make America Healthy Again' movement. Because of his status as a temporary government employee, Means is exempt from publicly disclosing his financial details. The AP reviewed more than two dozen interviews, speeches, articles and podcast appearances by Means both before and after he joined the government. Here are some takeaways from the AP's reporting: Attacking prescription drugs, promoting wellness alternatives Means' company, Truemed, helps users take tax-free money out of their health savings accounts, or HSAs, to spend on things that wouldn't normally qualify as medical expenses, such as meal delivery services and homeopathic products — remedies based on a centuries-old, debunked theory of medicine. As a top messenger for the administration, Means has been promoting a new government report that calls for scaling back prescription drugs for depression, weight loss and other conditions. By criticizing the use of drugs and other rigorously tested products, health experts say Means is furthering the interests of his company, which offers alternatives to traditional medicine. 'It reeks of hypocrisy,' said Dr. Reshma Ramachandran, a health researcher at Yale University. 'In effect, he is representing another industry that is touting nonregulated products and using his platform within the government to financially benefit himself.' In a written statement, Means said his government work has not dealt with matters affecting Truemed and has focused on issues like reforming nutrition programs and pressuring companies to phase out food dyes. 'Pursuing these large-scale MAHA goals to make America healthy has been the sole focus in my government work,' Means said. Undisclosed interests The full extent of Means' potential financial conflicts are unclear because of his status as a special government employee. Unlike presidential appointees and other senior officials, special government employees do not have to leave companies or sell investments that could be impacted by their work. Also, their financial disclosure forms are shielded from public release. 'It's a big problem,' says Richard Painter, former White House ethics lawyer under George W. Bush. 'I think it's a loophole." Plugging products and business associates While promoting the administration's accomplishments, Means has not shied away from plugging his own brand or those of his business partners. When asked to offer health advice to listeners of a sports podcast, Outkick The Show, in April, Means suggested they read his book "Good Energy,' which he co-authored with his sister, Dr. Casey Means. He also recommended blood tests sold by Function Health, which provides subscription-based testing for $500 annually. The company was cofounded by Dr. Mark Hyman, a friend of Kennedy and an investor in Truemed, which also offers Hyman's supplements through its platform. Like dietary supplements, the tests marketed by Function Health are not clinically approved by the Food and Drug Administration. 'It ends up favoring these products and services that rest on flimsy grounds, at the expense of products that have actually survived a rigorous FDA approval process,' said Dr. Peter Lurie, a former FDA official who is now president of the Center for Science in the Public Interest. Steering medical dollars into health savings accounts Means says he has not worked on issues impacting HSAs since joining the federal government. Federal ethics laws forbid government employees from taking part in decisions that could impact their financial situation. But before joining government, Means said the mission of his company 'is to steer medical dollars into flexible spending.' 'I want to get that $4.5 trillion of Medicare, Medicaid, everything into a flexible account,' he told fitness celebrity Jillian Michaels, on her podcast last year. Truemed collects fees when users and partnering companies use its platform. Means also founded a lobbying group, made up of MAHA entrepreneurs and TrueMed vendors, that listed expanding HSAs as a goal on its website. Means said in a statement that the group focused only on broad topics like 'health care incentives and patient choice — but did not lobby for specific bills.' Benefits of HSAs questioned Expanding HSAs has been part of the Republican health platform for more than 20 years. The tax-free accounts were created in 2003 to encourage Americans in high-deductible plans to be judicious with their health dollars. But HSAs have not brought down spending, economists say. They are disproportionately used by the wealthiest Americans, who have more income to fund them and bigger incentives to lower their tax rate. Americans who earn more than $1 million annually are the group most likely to make regular HSA contributions, according to an analysis by the nonprofit Center on Budget and Policy Priorities. Most Americans with HSAs have balances less than $500. HSA expansions in Trump's 'One Big Beautiful Bill' are projected to cost the federal government $180 billion over the next 10 years. 'These are really just tax breaks in the guise of health policy that overwhelmingly benefit people with high incomes,' said Gideon Lukens, a former White House budget official during the Obama and Trump administrations. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Yahoo
34 minutes ago
- Yahoo
In memo, Trump targets health care payments that 'game the system'
BOSTON (SHNS) – As the U.S. Senate prepares to take its own crack at legislation that includes hundreds of millions of dollars in cuts to Medicaid, the president late last week made his thoughts on one provision clear and it could impact how Massachusetts and other states finance public health care. Late on Friday, President Donald Trump issued a memo ordering U.S. Secretary of Health and Human Services Robert Kennedy Jr. to 'eliminate waste, fraud, and abuse in Medicaid, including by ensuring Medicaid payments rates are not higher than Medicare.' The move targeted state directed payments, a Medicaid financing mechanism that gives states flexibility to require managed care organizations to pay providers specific rates or to implement rate increases to advance delivery system or state policy objectives, most commonly improving access to care. State directed payments came about as a result of a 2016 Medicaid reform, but they have grown significantly in popularity since then. There were 250 unique directed payment arrangements approved between July 1, 2021 and Feb. 1, 2023, according to the Medicaid and CHIP Payment and Access Commission (MACPAC). The commission said the number increased by almost 21% to 302 unique arrangements approved between Feb. 1, 2023 and Aug. 1, 2024. The arrangements approved as of Aug. 1, 2024 were projected to spend a total of $110.2 billion a year, a 59% increase over the $69.3 billion in projected spending identified by the commission's analysis of arrangements approved as of Feb. 1, 2023. 'This trajectory threatens the Federal Treasury and Medicaid's long-term stability, and the imbalance between Medicaid and Medicare patients threatens to jeopardize access to care for our seniors,' Trump wrote in the memo. Trump said states and health care providers have used state directed payments 'to game the system,' echoing concerns previously raised by experts. The president outlined the scheme: states charge assessments on health care providers in order to nudge up reported state spending to score higher federal reimbursements, but then send 'the same money back to them in the form of a 'Medicaid payment,' which automatically unlocked for healthcare providers an additional 'burden-sharing' payment from the Federal Government.' 'Instead of paying Medicare rates, many States that utilize these arrangements now pay the same healthcare providers almost three times the Medicare amount,' the president said. The U.S. Centers for Medicare & Medicaid Service has approved 63 such arrangements for Massachusetts since March 2023, according to CMS data. The budget reconciliation bill passed last month by the U.S. House and expected to be taken up this month by the U.S. Senate would, among many other things, extend Trump's first-term tax cuts and reduce Medicaid spending by nearly $700 billion to help pay for it. Officials at MassHealth, which combines Medicaid and the Children's Health Insurance Program, have said the Bay State could be in jeopardy of losing more than $1 billion annually, with hundreds of thousands of residents at risk of losing coverage. Health policy nonprofit KFF said the bill directs U.S. Health and Human Services to revise state directed payment regulations so that the total payment rate for inpatient hospital and nursing facility services is capped at 100% of the total published Medicare payment rate. The 100% limit would apply to Massachusetts and other states that have adopted the Medicaid expansion, and the limit would be 110% for the 10 states that have not adopted the expansion. But the U.S. House version of the bill would grandfather in any state directed payments submitted for approval and approved prior to the legislation's enactment. MassHealth has previously said that so-called safety net providers could sustain cuts of hundreds of millions of dollars annually if Congress or the president blocks renewal of Massachusetts's existing state directed payments. MassHealth and the Mass. Executive Office of Health and Human Services did not respond over the weekend or Monday to a request for comment on the president's memo on state directed payments. Manatt Health Senior Managing Director Patricia Boozang said in March that Massachusetts uses state directed payments 'extensively' and that the Trump administration was likely to act on its own to address them if the president's favored policies don't advance as part of the reconciliation package. The Congressional Budget Office said last month that the bill as passed by the U.S. House will mean $698 billion less in federal subsidies for Medicaid, $267 billion less in federal spending for SNAP, $64 billion less in net spending for all other purposes, and a $3.8 trillion increase in the federal deficit all over the next decade. The CBO also said it expects the reductions in federal spending to lead to about $78 billion in additional spending among the 50 states 'accounting for changes in state contributions to SNAP and Medicaid and for state tax and spending policies necessary to finance additional spending.' The office said it was still analyzing 'expectations of the states' responses to changes in federal funding.' The budget plans that House and Senate negotiators are attempting to reconcile into a final fiscal 2026 state budget assume about $15.76 billion in federal revenues, an increase over the $14.3 billion in the current budget, including $14.2 billion in federal MassHealth reimbursements alone. Most of the cuts in the U.S. House bill would hit in federal fiscal year 2027, which begins Oct. 1, 2026 (three months into Massachusetts' fiscal year 2027). Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.